We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 28 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  2. マーケットリサーチセンター Tokyo//Service Industry
  3. ケーナインラボ Tokyo//Testing, Analysis and Measurement
  4. 4 null/null
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. K9 Lab Inc. Company Profile ケーナインラボ
  3. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  4. 4 Pharmaceutical CDMO services 大塚化学
  5. 4 Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン

medicine Product List

76～90 item / All 537 items

Displayed results
[Research Material] Global Market for Tourette Syndrome Treatment Drugs

[Research Material] Global Market for Tourette Syndrome Treatment Drugs

World Market for Tourette Syndrome Treatments: AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipa ...

This research report (Global Tourette Syndrome Drug Market) investigates and analyzes the current state and future outlook of the global market for Tourette syndrome treatment drugs over the next five years. It includes information on the overview of the global Tourette syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, and Others, while the segments by application focus on research centers, hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Tourette syndrome treatment drugs. The report also includes the market share of major companies in the Tourette syndrome treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Cushing's Syndrome Treatment

[Research Material] The Global Market for Cushing's Syndrome Treatment

World Market for Cushing's Syndrome Treatment: Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others, Hospital Pharmacies, Small ...

This research report (Global Cushing's Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for Cushing's syndrome treatment over the next five years. It includes information on the overview of the global Cushing's syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Cushing's syndrome treatment market include glucocorticoid receptor antagonists, somatostatin, ketoconazole HRA, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Cushing's syndrome treatment. It also includes the market share of major companies in the Cushing's syndrome treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for mRNA Vaccines and Therapeutics

[Research Material] Global Market for mRNA Vaccines and Therapeutics

Global Market for mRNA Vaccines and Therapeutics: Infectious Disease Vaccines, Cancer Vaccines, Infectious Diseases, Cancer, Others

This research report (Global mRNA Vaccines & Therapeutics Market) investigates and analyzes the current state and future outlook of the global mRNA vaccine and therapeutic market over the next five years. It includes information on the overview of the global mRNA vaccine and therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on infectious disease vaccines and cancer vaccines, while the segments by application target infectious diseases, cancer, and others. The regional segments calculate the market size of mRNA vaccines and therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the mRNA vaccine and therapeutic market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

Global Market for Treatment Drugs for Myotonic Dystrophy: ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others...

This research report (Global Myotonic Dystrophy Drug Market) investigates and analyzes the current state and outlook for the global market for myotonic dystrophy treatments over the next five years. It includes information on the overview of the global myotonic dystrophy drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type include ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others, while the segments by application focus on hospitals, clinics, home care, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myotonic dystrophy treatments. It also includes the market share of major companies in the myotonic dystrophy drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Treatments

[Research Material] Global Market for Rare Disease Treatments

Global Market for Rare Disease Treatments: Originator Drugs, Generic Drugs, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies

This research report (Global Rare Disease Treatment Market) investigates and analyzes the current state of the global market for rare disease treatments and its outlook for the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare disease treatment market focus on originator drugs and generic drugs, while the segments by application target hospital pharmacies, specialty pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. It also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

World Market for Oropharyngeal Cancer Treatments: BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others...

This research report (Global Nasopharyngeal Cancer Drug Market) investigates and analyzes the current status and outlook for the global market of nasopharyngeal cancer treatments over the next five years. It includes information on the overview of the global nasopharyngeal cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for nasopharyngeal cancer treatments. It also includes the market share of major companies in the nasopharyngeal cancer drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

Global Market for Epidermolysis Bullosa Treatment Drugs: EB-201, FCX-007, ICX-RHY, INM-750, Others, Clinics, Hospitals, Others

This research report (Global Epidermolysis Bullosa Therapeutics Market) investigates and analyzes the current status and future outlook of the global market for epidermolysis bullosa therapeutics over the next five years. It includes information on the overview of the global epidermolysis bullosa therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include EB-201, FCX-007, ICX-RHY, INM-750, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for epidermolysis bullosa therapeutics. It also includes the market share of major companies in the epidermolysis bullosa therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments

[Research Material] Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments

Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments: SGD-2083, Crizanlizumab, PF-04447943, NVX-50 ...

This research report (Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease) investigates and analyzes the current state and outlook for the global market of vaso-occlusive crises associated with sickle cell disease treatments over the next five years. It includes information on the overview of the global market for vaso-occlusive crises associated with sickle cell disease treatments, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for vaso-occlusive crises associated with sickle cell disease treatments include SGD-2083, crizanlizumab, PF-04447943, NVX-508, and others, while the segments by application include clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for vaso-occlusive crises associated with sickle cell disease treatments. The report also includes the market share of major companies in the vaso-occlusive crises associated with sickle cell disease treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Hematology Treatments

[Research Material] Global Market for Rare Hematology Treatments

Global Market for Rare Hematology Treatments: Plasma-Derived Factors, Recombinant Factors, Hemophilia A, Hemophilia B, von Willebrand Disease, Others

This research report (Global Rare Hematology Treatment Market) investigates and analyzes the current state and outlook for the global market of rare hematology treatments over the next five years. It includes information on the overview of the global rare hematology treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare hematology treatment market focus on plasma-derived factors and recombinant factors, while the segments by application target hemophilia A, hemophilia B, von Willebrand disease, and others. The regional segments calculate the market size for rare hematology treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare hematology treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for the Treatment of Psoriasis

[Research Material] The Global Market for the Treatment of Psoriasis

World Market for Psoriasis Treatment: Topical Therapy, Phototherapy, Systemic Drugs, Biological Therapy, Hospitals, Clinics, Others

This research report (Global Plaque Psoriasis Treatment Market) investigates and analyzes the current state and outlook for the global market for the treatment of psoriasis over the next five years. It includes information on the overview of the global psoriasis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the psoriasis treatment market focus on topical therapies, phototherapy, systemic drugs, and biological therapies, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for psoriasis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in psoriasis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ovarian Cancer Treatment Drugs

[Research Material] Global Market for Ovarian Cancer Treatment Drugs

Global Market for Ovarian Cancer Treatments: PARP, PD-L1, Angiogenesis Inhibitors, Hospitals, Research

This research report (Global Ovarian Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for ovarian cancer therapeutics over the next five years. It includes information on the overview of the global ovarian cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on PARP, PD-L1, and angiogenesis inhibitors, while the segments by application target hospitals and research. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ovarian cancer therapeutics. It also includes the market share of major companies in the ovarian cancer therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Small Interfering RNA (siRNA) Therapeutics

[Research Material] Global Market for Small Interfering RNA (siRNA) Therapeutics

Global Market for Low Molecular Weight Interfering RNA (siRNA) Therapeutics: Liposome-based Systemic Therapy, Nanoparticle-based Systemic Therapy, Others, Hospitals, Research Institutions ...

This research report (Global Small Interfering RNA (siRNA) Therapeutics) investigates and analyzes the current status and future outlook of the global market for small interfering RNA (siRNA) therapeutics over the next five years. It includes information on the global overview of the small interfering RNA (siRNA) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for small interfering RNA (siRNA) therapeutics by type include liposome-based systemic therapy, nanoparticle-based systemic therapy, and others, while the segments by application target hospitals, research institutions, pharmaceutical and biotechnology companies, academic institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for small interfering RNA (siRNA) therapeutics. The report also includes information on the market share of major companies in the small interfering RNA (siRNA) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Intestinal Bacterial Infections

[Research Material] Global Market for Treatments of Intestinal Bacterial Infections

World Market for Treatments of Intestinal Bacterial Infections: Beta-lactam Drugs, Carbapenem Drugs, Fluoroquinolone Drugs, Others, Hospital Pharmacies, Retail Pharmacies ...

This research report (Global Enterobacteriaceae Infection Drug Market) investigates and analyzes the current status and outlook for the global market of drugs for treating Enterobacteriaceae infections over the next five years. It includes information on the overview of the global Enterobacteriaceae infection drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-lactam drugs, carbapenem drugs, fluoroquinolone drugs, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Enterobacteriaceae infection drugs. It also includes the market share of major companies in the Enterobacteriaceae infection drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment Drugs

[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment Drugs

World Market for Acute Lymphoblastic Leukemia Treatment Drugs: Chemotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation, Hospitals, Pharmacies

This research report (Global Acute Lymphoblastic Leukemia Therapeutics M) investigates and analyzes the current state and outlook for the global market of acute lymphoblastic leukemia therapeutics over the next five years. It includes information on the overview of the global acute lymphoblastic leukemia therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include chemotherapy, targeted therapy, radiation therapy, and stem cell transplantation, while the segments by application focus on hospitals and pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute lymphoblastic leukemia therapeutics. It also includes the market share of major companies in the acute lymphoblastic leukemia therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Dermatophyte Nail Fungal Infection (DOT)

[Research Material] Global Market for Treatment of Dermatophyte Nail Fungal Infection (DOT)

Global Market for Treatment of Dermatophyte Nail Fungal Infections (DOT): Systemic Therapy, Topical Therapy, Others, Hospitals, Dermatology Clinics, Others

This research report (Global Dermatophytic Onychomycosis Treatment Market) investigates and analyzes the current state and future outlook of the global market for dermatophytic onychomycosis treatment (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis treatment (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis treatment (DOT) by type include systemic therapy, topical therapy, and others, while the segments by application focus on hospitals, dermatology clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for dermatophytic onychomycosis treatment (DOT). It also includes the market share of major companies in dermatophytic onychomycosis treatment (DOT), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.